MedPath

贵州润生制药有限公司

Ownership
-
Established
1995-11-14
Employees
-
Market Cap
-
Website
www.gzrszy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

杜仲颗粒

Approval Number
国药准字Z20194054
Approval Date
Jul 11, 2024
NMPA

补肾强身片

Approval Number
国药准字Z20194053
Approval Date
Jul 11, 2024
NMPA

Tinidazole Vaginal Effervescent Tablets

Product Name
替硝唑阴道泡腾片
Approval Number
国药准字H20194045
Approval Date
Jun 21, 2024
NMPA

Ferrous Fumarate Granules

Product Name
富马酸亚铁颗粒
Approval Number
国药准字H20194044
Approval Date
Jun 21, 2024
NMPA

首乌延寿片

Approval Number
国药准字Z20194052
Approval Date
Jun 21, 2024
NMPA

六味消痔片

Approval Number
国药准字Z20083322
Approval Date
Apr 18, 2023
NMPA

Propacetamol Hydrochloride for Injection

Product Name
注射用盐酸丙帕他莫
Approval Number
国药准字H20143256
Approval Date
Aug 5, 2021
NMPA

Propacetamol Hydrochloride for Injection

Product Name
注射用盐酸丙帕他莫
Approval Number
国药准字H20066535
Approval Date
Apr 29, 2021
NMPA

Dexibuprofen Suppositories

Product Name
右旋布洛芬栓
Approval Number
国药准字H20010642
Approval Date
Aug 17, 2020
NMPA

金果榄涂膜剂(金果榄凝胶)

Approval Number
国药准字Z20025274
Approval Date
Dec 13, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath